Human primary cell culture medium and application thereof

A primary cell and culture medium technology, applied in tissue culture, culture, microorganisms, etc., can solve problems such as troublesome operation steps, insufficient practicability, and differences in primary cell culture effects, and achieve high amplification efficiency and long culture time Effect

Active Publication Date: 2016-04-20
GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] In 2009, an article entitled "Long–termcultureofprimaryhumanlymphoblasticleukemiacellsintheabsenceofserumorhematopoieticgrowthfactors" mentioned the in vitro medium of primary lymphocytic leukemia cells, which was a serum-free IMDM medium supplemented with cytokines IL-3, IL-7, and SCF; Although the medium does not contain serum, the inventors of the present invention conducted repeated experiments using the medium and found that the culture effect described in the article cannot be achieved, that is, its stability needs to be studied;
[0010] It should be noted that although serum is necessary for the survival and culture of traditional cells in vitro, when human primary cells are cultured in vitro, serum can accelerate the differentiation and aging of primary cells, especially hematopoietic stem cells and progenitor cells; Moreover, as far as the serum itself is concerned, even if it is the serum of the same brand, there may be obvious differences between different batches of serum, which m

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human primary cell culture medium and application thereof
  • Human primary cell culture medium and application thereof
  • Human primary cell culture medium and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Example 1 evaluates the success rate of culturing human primary B-ALL cells in vitro using the culture medium of the present invention

[0047] Human primary B-ALL cells were isolated and obtained by density centrifugation, and the specific steps were as follows:

[0048] 1) Mix the bone marrow or peripheral blood samples of B-ALL patients with normal saline in equal proportions;

[0049] 2) Into a new 15mL centrifuge tube, add one-half of the volume of diluted blood lymphatic separation solution (Lymphoprep, StemCellTechnologies);

[0050] 3) Slowly superimpose the diluted blood on the layered liquid surface along the wall of the centrifuge tube, keeping the liquid surface clear;

[0051] 4) Gently put the bone marrow sample mixture centrifuge tube into the centrifuge, and centrifuge at 800g / min for 20min;

[0052] 5) Gently take out the centrifuge tube, layer the bone marrow sample mixture, use a Pasteur pipette to carefully absorb the cells in the middle cloud la...

Embodiment 2

[0059] Example 2 evaluates the cell viability of culturing human primary B-ALL cells in vitro using the culture medium of the present invention

[0060] Using the human primary B-ALL cell sample prepared in Example 1, using the control medium containing serum but not containing cytokine combination as a control, evaluate the cell survival of human primary B-ALL cells cultured in vitro using the medium of the present invention Rate. The composition of the control medium is: IMDM+10%FBS+1% / P / S+5mM glutamate; the composition of the medium of the present invention is: IMDM+1% / P / S+5mM glutamate+cytokines combination , the composition and content of the cytokine combination are shown in the following table:

[0061] Element

concentration

BSA

1mg / ml

Transferrin

10ug / ml

insulin

10ug / ml

humanFLT3L

100ng / ml

[0062] hIGF1

100ng / ml

hIL-7

50ng / ml

hIL-6

50ng / ml

[0063] Specific...

Embodiment 3

[0065] Example 3 Use the culture medium of the present invention to culture the cell growth curve of human primary B-ALL cells in vitro

[0066] Using the human primary B-ALL cell sample prepared in Example 1, using the control medium containing serum but not containing cytokine combination as a control, evaluate the cell growth of human primary B-ALL cells cultured in vitro using the medium of the present invention situation. The composition of the control medium is: IMDM+10%FBS+1% / P / S+5mM glutamate; the composition of the medium of the present invention is: IMDM+1% / P / S+5mM glutamate+cytokines combination , the composition and content of the cytokine combination are shown in the following table:

[0067] Element

concentration

BSA

5mg / ml

5

5ug / ml

insulin

5ug / ml

humanFLT3L

50ng / ml

hIGF1

50ng / ml

hIL-7

20ng / ml

hIL-6

20ng / ml

[0068] Specifically, the 5×10 5 The primary B-ALL cel...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a human primary cell culture medium, and the culture medium is used for the culture of human primary cells in vitro and the culture of human primary B acute lymphocyte leukemia (B-ALL) in vitro. The culture medium also comprises cell factors: human FLT3L, human IGF1, human IL-7 and human IL-6. The culture medium does not contain serum, and can prevent the co-culture of primary cells and matrix cells, and also solves a series of problems in conventional schemes of serum and matrix cell culture. Compared with a conventional culture mode, a mode of employing the culture medium is higher in amplification efficiency, and is longer in time of culture in vitro.

Description

technical field [0001] The present invention relates to the technical field of cell culture, in particular to a primary cell culture medium, the use of the medium for culturing human primary cells in vitro, and the use of the culture medium for culturing primary human acute lymphoblastic leukemia (B- ALL) cell method. Background technique [0002] B-cell acute lymphoblastic leukemia (B-ALL, B-cellacutelymphoblasticleukemia), also known as precursor B-cell (preB-cell) acute lymphoblastic leukemia, is a malignant tumor derived from B-cell progenitor cells. B-ALL is mainly a high-incidence cancer in children, and its incidence rate decreases in adults. Prognosis is good in juvenile patients with B-ALL, and the long-term survival rate (EFS, event-free survival) can reach 90%, but it is poor prognosis and low survival rate in B-ALL adults. In addition, in adult B-ALL patients, the effect of traditional chemotherapy is poor, and the mortality rate is about 60%. Therefore, there...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A99Z99/00
CPCC12N5/00
Inventor 李鹏蒋治武林思妙叶未姚瑶
Owner GUANGZHOU INST OF BIOMEDICINE & HEALTH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products